Tambalque, Jennimel P.
HRN: 22-87-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2023
CEFUROXIME 500MG (TAB)
06/07/2023
06/14/2023
PO
500mg
BID
S/P NSVD With 2nd Degree RMLE And Repair
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes